Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2020-07-26 Capital/Financing Update
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Appendix 3G 13 pages 224.4KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3G form submitted to the ASX, which is a notification of the issue, conversion, or payment up of equity securities. It details the issuance of unquoted securities under an employee incentive scheme, including the number and type of securities issued, the purpose, and other related information. This type of document is a formal announcement regarding changes in the company's capital structure, specifically the issuance of new securities. It is not a full financial report, earnings release, or management discussion, nor is it a proxy or AGM material. It is a capital/financing update related to securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2020-07-26 English
Appendix 2A 15 pages 231.7KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of securities' and is structured as a form for applying to the ASX for quotation of securities. It includes detailed questions about the entity, the type of securities, and specifics about securities issued under an employee incentive scheme. The document is a formal application related to the listing or quotation of securities on the stock exchange, not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a regulatory filing related to securities quotation. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-06-30 English
Appendix 3Y Change of Director's Interest Notice 2 pages 168.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares and rights held before and after the change, nature of the change, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3505 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2020-06-30 English
Ceasing to be a substantial holder 4 pages 1.1MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under Corporations Law Section 671B. It details changes in substantial shareholding interests, dates of changes, and includes annexures listing registered shareholdings and net trades. This type of filing is a notification about changes in major share ownership levels, specifically the cessation of substantial holding status. It is not a financial report, earnings release, or management report. It fits the definition of a Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not just an announcement or certification.
2020-06-29 English
Sale of Medical Centres and Market Update 3 pages 172.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement from Healius Limited dated 15 June 2020. It details the sale of the Medical Centres business for $500 million, provides a market update including revenue recovery and banking facility refinancing, and discusses strategic implications of the sale. The content focuses on a significant transaction (sale of a business segment) and financing update (refinancing of bank debt facility). There is no detailed financial statement or comprehensive financial report data, nor is it a transcript or presentation. The document is a corporate announcement about a capital transaction and financing update. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (over 10,000 characters) and detailed transaction terms confirm it is not a brief announcement or a report publication announcement.
2020-06-14 English
Investor Presentation - Sale of Medical Centres 8 pages 583.8KB
Investor Presentation Classification · 95% confidence The document is titled 'Portfolio simplification through sale of Medical Centres' dated 15 June 2020. It discusses strategic and financial benefits of a sale, portfolio simplification, financial performance, trading update, and future outlook. The content focuses on business strategy, asset sales, and financial implications rather than detailed financial statements or regulatory filings. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document appears to be an investor presentation or strategic update aimed at shareholders and investors, highlighting the company's portfolio changes and financial outlook. The length (8577 characters) and the presence of charts and strategic commentary support classification as an Investor Presentation (IP).
2020-06-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.